unexpected safety data in treasure: thoracic radiotherapy with atezolizumab in sclc
Published 10 months ago • 45 plays • Length 2:36Download video MP4
Download video MP3
Similar videos
-
0:42
beat-sc: phase iii trial of bevacizumab or placebo with atezolizumab & chemo in extensive-stage sclc
-
2:33
concurrent immunotherapy in sclc
-
5:36
ipsos: 1l atezolizumab vs single-agent chemotherapy in patients with platinum-ineligible nsclc
-
0:54
celebrate: carboplatin, etoposide, bevacizumab and atezolizumab in extensive-stage sclc
-
0:55
the potential of targeted and immune therapies in sclc
-
1:41
adjuvant atezolizumab in nsclc
-
1:50
impower133: atezolizumab, carboplatin plus etoposide for sclc
-
9:45
high-dose twice daily thoracic radiotherapy in limited disease small-cell lung cancer
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc
-
3:28
advanced-stage nondriver nsclc: impower150 trial
-
1:03
sangeetha palakurthi on fda approval of atezolizumab in nsclc
-
4:18
impower110: atezolizumab vs chemo in pd-l1–selected nsclc
-
2:35
atezo maintenance therapy improves survival in the impower133 trial of es-sclc
-
0:26
results of celebrate: carboplatin, etoposide, bevacizumab atezolizumab es-sclc
-
1:58
impower 010: adjuvant atezolizumab in nsclc - onctalk lung 2023
-
1:15
dr. rudin discusses the success of immunotherapy in sclc
-
2:15
dr. wakelee on birch trial for atezolizumab in patients with nsclc
-
1:27
fda approval of atezolizumab for nsclc
-
3:30
princeps study: atezolizumab for resectable nsclc